Part 5/7:
The potential applications of CL1 are vast, with immediate implications for drug testing and personalized medicine. By cultivating neurons derived from a patient’s own cells, researchers can test how that individual's brain might respond to various drugs or treatments, enabling truly personalized therapies for conditions like dementia, epilepsy, or other neurological disorders.
Han Wang Chong envisions a future where this technology can revolutionize the way we approach disease treatment, reducing reliance on trial-and-error methods and accelerating the development of effective medicines. Furthermore, the CL1 could facilitate the study of complex neurological conditions in a controlled environment, improving our understanding of the human brain.